End-Stage Renal Disease (ESRD)Symptoms, Doctors, Treatments, Advances & More
Learn About End-Stage Renal Disease (ESRD)
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Harbor-UCLA Nephrology
Kamyar Kalantar-Zadeh is an Internal Medicine provider practicing medicine in Torrance, California. Dr. Kalantar-Zadeh is rated as an Elite provider by MediFind in the treatment of End-Stage Renal Disease (ESRD). He is also highly rated in 41 other conditions, according to our data. His clinical expertise encompasses Chronic Kidney Disease, Hypertension, High Potassium Level, Kidney Transplant, and Nephrectomy. Dr. Kalantar-Zadeh is board certified in Interal Medicine, Nephrology, and Pediatrics.
Hale Building For Transformative Medicine On BWH Main Campus
Karen Costenbader is a Rheumatologist practicing medicine in Boston, Massachusetts. Dr. Costenbader is rated as an Elite provider by MediFind in the treatment of End-Stage Renal Disease (ESRD). She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Systemic Lupus Erythematosus (SLE), Lupus Nephritis, End-Stage Renal Disease (ESRD), Rheumatoid Arthritis (RA), and Knee Replacement. Dr. Costenbader is currently accepting new patients.
Suburban Geriatrics Inc
Robert Pearlstein is a primary care provider, practicing in Geriatrics and Internal Medicine in Plymouth Meeting, Pennsylvania. Dr. Pearlstein is rated as a Distinguished provider by MediFind in the treatment of End-Stage Renal Disease (ESRD). He is also highly rated in 180 other conditions, according to our data. His clinical expertise encompasses Dementia, Alzheimer's Disease, Painful Swallowing, Gastrostomy, and Endoscopy. Dr. Pearlstein is board certified in . Dr. Pearlstein is currently accepting new patients.
Summary: During end-stage kidney disease, clinical guidelines suggest reducing elevated phosphate levels in the blood. However, the effect of lowering blood phosphate levels on important patient-centred outcomes has never been tested. This trial will evaluate whether compared to high levels, lowering blood phosphate levels would reduce death or major events due to heart disease, improve physical health, an...
Summary: This is a multicenter, prospective, observational real-world study designed to evaluate clinical effectiveness, quality of life, and healthcare resource utilization in patients with end-stage renal disease (ESRD) initiating dialysis therapy in China. Participants will be grouped according to the dialysis modality selected through routine clinical practice and shared decision-making with their trea...